🚀 go-pugleaf

RetroBBS NetNews Server

Inspired by RockSolid Light RIP Retro Guy

Article View: be.science
Article #338

Cancer - Press review (November 5, 2011) – Revue de presse (5 novembre 2011)

#338
From: SciMedWeb
Date: Sat, 05 Nov 2011 07:10
165 lines
8321 bytes
Cancer – Press Review  – Revue de Presse

Every week on http://marclacroixcancerblog.blogspot.com
Chaque semaine sur http://marclacroixcancerblog.blogspot.com




Press review  (November 5, 2011) – Revue de presse (5 novembre 2011)


Axitinib Looks Good in Head-to-Head Renal Cancer Trial‎
The second-generation targeted agent axitinib was better at preventing
kidney cancer progression than the older drug sorafenib (Nexavar) in a
randomized trial, researchers found.
By Michael Smith. In MedPageToday
http://www.medpagetoday.com/HematologyOncology/OtherCancers/29441

Data Links High Doses of Bone Drug to Cancer
A Medtronic product, when used in high doses during spinal fusion
procedures, might increase patient cancer risks, according to data
released Thursday at a national conference of spine surgeons.
By Barry Meier. In The New York Times
http://www.nytimes.com/2011/11/04/health/research/amplify-by-medtronic-may-raise-chance-of-cancer-data-shows.html

Key To Fighting Cancer Is To Stay Active
Decades of research have produced a simple, clear message: Being
active is healthy, and physical inactivity is not. Exercise is
necessary to stay fit and to stave off America's biggest killers –
heart disease, diabetes and cancer.
By Carrie Gann. ABC News
http://abcnews.go.com/Health/sitting-give-cancer/story?id=14876776

ASCO Unveils New Vision for Transforming Cancer Research
Although there has been tremendous progress in cancer care during the
past 40 years, there is still much to be done to improve patient
survival. In a new report, the American Society of Clinical Oncology
(ASCO) has issued a detailed "prescription" for transforming clinical
research and increasing the pace of drug development.
By Roxanne Nelson. In Medscape
http://www.medscape.com/viewarticle/752949

Common Breast Cancer Gene Test May Be Flawed, Study Says
A widely used breast cancer test may not be accurate in identifying a
gene that is critical in determining which life-saving treatment a
woman should get.
By Amanda Gardner. In U.S. News & World Report
http://health.usnews.com/health-news/family-health/cancer/articles/2011/11/04/common-breast-cancer-gene-test-may-be-flawed-study-says

Embryonic signal drives pancreatic cancer and offers a way to kill it
Pancreatic cancer is a particularly challenging one to beat; it has a
tendency to spread and harbors cancer stem cells that stubbornly
resist conventional approaches to therapy. Now, researchers reporting
in Cell Stem Cell, have evidence to suggest there is a way to kill off
those cancer stem cells. The target is a self-renewal pathway known
for its role not in cancer but in embryonic stem cells.
In ecancermedicalscience
http://www.ecancermedicalscience.com/news-insider-news.asp?itemId=2121

Cancer risk doubles after organ transplant, study finds‎‎
Organ transplant recipients in the United States double their risk of
developing cancer compared to the general population. And that risk is
elevated for 32 different types of cancer, according to new research.
By Serena Gordon. In USA Today
http://yourlife.usatoday.com/health/medical/cancer/story/2011-11-02/Cancer-risk-doubles-after-organ-transplant-study-finds/51040454/1

FDA says drugs approved in US before Europe
Americans in the past year got access to 24 new medicines before they
became available anywhere else, U.S. drug regulators said as they seek
to show they are doing enough to promote medical innovation.
By John Gress and Lisa Von Ahn. In Reuters
http://www.reuters.com/article/2011/11/04/us-fda-approvals-idUSTRE7A26U820111104

Lung cancer patients with high EGFR expression live longer with
cetuximab treatment
Patients with the most common form of lung cancer whose tumours
express high levels of epidermal growth factor receptor (EGFR) are
more likely to benefit from cetuximab treatment and live longer
compared with those given chemotherapy alone, according to a study
published in The Lancet Oncology.
In ecancermedicalscience
http://www.ecancermedicalscience.com/news-insider-news.asp?itemId=2109

Même une faible consommation d'alcool accroît le risque de cancer du
sein
Consommer de trois à six verres de vin par semaine accroîtrait le
risque de cancer du sein de 15% selon une étude dont les résultats
sont publiés mardi dans le Journal of the American Medical Association
(JAMA). AFP
http://www.google.com/hostednews/afp/article/ALeqM5j8V8nY1NKQOoPZNB8DYWTI_aI7qQ?docId=CNG.be461a0ef83e9eabbab05764945a599b.951

Cancer : Un problème de santé publique
Initié par l’Association internationale de lutte contre le cancer, un
atelier regroupe depuis hier jeudi les médecins du Mali (toute
spécialisations confondues) autour de la prise en charge de cette
maladie.
Par David Dembele. Dans Le Journal du Mali
http://www.journaldumali.com/article.php?aid=3823

Le cancer devient le pire ennemi des Canadiens‎‎
Pour la première fois, le cancer est devenu la principale cause de
décès au Canada en 2008. L'année précédente, le cancer était la
première cause de décès à travers le pays sauf à l'Ile-du-Prince-
Édouard et dans les Territoires du Nord-Ouest.
Cyberpresse
http://www.cyberpresse.ca/actualites/quebec-canada/sante/201111/01/01-4463376-le-cancer-devient-le-pire-ennemi-des-canadiens.php

L'aspirine réduit le taux de cancer colorectal chez des sujets à haut
risque
La prise d'aspirine à long terme préviendrait le cancer colorectal
chez des personnes à très haut risque héréditaire, selon une étude
publiée vendredi, montrant chez elles une réduction de plus de moitié
du nombre de cas observés.
AFP
http://www.google.com/hostednews/afp/article/ALeqM5iOFlQBhBJtkfeGmvghlT2wWk274Q?docId=CNG.fd8b192737a8b42331c2853a45a1363c.b1

Le vaccin anti-papillomavirus humains préviendrait le cancer anal‎
Le vaccin contre les papillomavirus humains (HPV), transmis
sexuellement et responsables de nombreux cancers utérins, s'est avéré
efficace pour prévenir des infections et lésions anales pré-
cancéreuses chez des hommes homosexuels, selon une étude clinique
publiée mercredi.
AFP
http://www.google.com/hostednews/afp/article/ALeqM5g3VUfLEhfYqPgR9QkC1JnPXAKUTg?docId=CNG.ca83feaf2a770de47c03ff7c91039ecc.291








Cancer Blog – Marc Lacroix – Le Blogue du Cancer
http://marclacroixcancerblog.blogspot.com










Marc Lacroix – InTextoResearch – Baelen  (11/2011)
Technical Details
Message-ID: <ade6a369-0592-4444-8c53-fd9127dca2d8@hv4g2000vbb.googlegroups.com>
Path: arc1-ca.pugleaf.net!p6ni73203pbn.0!nntp.google.com!news2.google.com!postnews.google.com!hv4g2000vbb.googlegroups.com!not-for-mail

Show Full Headers
Complete Article Headers
X-Google-Thread: f5500,93e7dee47acf421e,start
X-Google-NewGroupId: yes
X-Google-Attributes: gida254ea4a8d,domainid0,public,usenet
X-Google-Language: ENGLISH,UTF8
Received: by 10.42.146.136 with SMTP id j8mr7907367icv.8.1320477944682;
        Sat, 05 Nov 2011 00:25:44 -0700 (PDT)
Path: arc1-ca.pugleaf.net!p6ni73203pbn.0!nntp.google.com!news2.google.com!postnews.google.com!hv4g2000vbb.googlegroups.com!not-for-mail
From: SciMedWeb <scimedweb@mail.com>
Newsgroups: be.science
Subject: Cancer - Press review  (November 5, 2011) – Revue de presse (5 novembre 2011)
Date: Sat, 5 Nov 2011 00:10:12 -0700 (PDT)
Organization: http://groups.google.com
Lines: 165
Message-ID: <ade6a369-0592-4444-8c53-fd9127dca2d8@hv4g2000vbb.googlegroups.com>
NNTP-Posting-Host: 87.65.232.140
Mime-Version: 1.0
X-Trace: posting.google.com 1320477944 7666 127.0.0.1 (5 Nov 2011 07:25:44 GMT)
X-Complaints-To: groups-abuse@google.com
NNTP-Posting-Date: Sat, 5 Nov 2011 07:25:44 +0000 (UTC)
Complaints-To: groups-abuse@google.com
Injection-Info: hv4g2000vbb.googlegroups.com; posting-host=87.65.232.140; posting-account=jR3pwAkAAABfF7uqn-zMzWqez-yhPWKE
User-Agent: G2/1.0
X-Google-Web-Client: true
X-Google-Header-Order: UHALERCNK
X-HTTP-UserAgent: Opera/9.80 (Windows NT 5.1; U; fr) Presto/2.8.131 Version/11.11,gzip(gfe)
Content-Type: text/plain; charset=UTF-8
Content-Transfer-Encoding: quoted-printable